Prevalence and factors associated with cutaneous manifestations of type 2 diabetes mellitus

被引:0
|
作者
Rasid, Saadah [1 ]
Muthupalaniappen, Leelavathi [1 ]
Jamil, Adawiyah [1 ]
机构
[1] Pusat Perubatan Univ Kebangsaan Malaysia, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
来源
CLINICAL DIABETOLOGY | 2020年 / 9卷 / 06期
关键词
diabetes mellitus; skin manifestations; glycated hemoglobin A; prevalence; SKIN;
D O I
10.5603/DK.2020.0049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Type 2 diabetes mellitus (T2DM) is known to cause multiple systemic manifestations. However, there are limited studies describing cutaneous manifestation among T2DM in Malaysia. The objective of this study was to determine the prevalence of cutaneous manifestation among T2DM patients, types of lesions and its associated factors. Methods. A cross-sectional study was conducted among 271 T2DM patients at a primary care clinic in Kuala Lumpur. Results. More than one third (63.5%) of patients were found to have cutaneous manifestations of T2DM. The most common manifestation was infections (34.7%) followed by Skin Diseases with Weak to Strong Association with Diabetes (SDWSAD) (31.7%), Skin Manifestation of Diabetic Complication (SMDC) (2.2%) and others cutaneous lesions (22.1%). Among the infections, onychomycosis was the commonest type of infection (27.7%) while diabetic dermopathy was the commonest lesion of SDWSAD (29.7%). Males had almost two times the odds of developing cutaneous manifestations of T2DM, compared to females (adjusted odds ratio [AOR]: 1.871, 95% CI: 1.108-3.160; P = 0.019). There was no association between glycemic control and cutaneous manifestations. However, males and those with T2DM duration of five years and more had 2.6 times the odds of developing SDWSAD (AOR: 2.646, 95% CI: 1.506-4.648 P = 0.001) and (AOR: 2.635, 95% CI: 1.107-6.268, P = 0.028) respectively. Those with diabetic neuropathy and peripheral vascular disease (PVD) had very high odds of developing SMDC such as diabetic foot and trophic ulcers (AOR: 23.259, 95% CI: 1.191-454.2, P = 0.038) and (AOR: 102.36, 95% CI: 4.013-2610, P = 0.005), respectively. Conclusion. The knowledge of these cutaneous manifestations increases physician's awareness and prompts early screening to reduce morbidity improve quality of life.
引用
收藏
页码:461 / 468
页数:8
相关论文
共 50 条
  • [21] Cutaneous Manifestations of Diabetes Mellitus and Prediabetes
    Sanches, Maria Mendonca
    Roda, Angela
    Pimenta, Rita
    Filipe, Paulo Leal
    Freitas, Joao Pedro
    ACTA MEDICA PORTUGUESA, 2019, 32 (06): : 459 - 465
  • [22] CUTANEOUS MANIFESTATIONS OF DIABETES-MELLITUS
    HUNTLEY, AC
    DIABETES-METABOLISM REVIEWS, 1993, 9 (03): : 161 - 176
  • [23] CUTANEOUS MANIFESTATIONS OF DIABETES-MELLITUS
    JELINEK, JE
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (01) : 143 - 143
  • [24] CUTANEOUS MANIFESTATIONS OF DIABETES-MELLITUS
    HUNTLEY, AC
    DERMATOLOGIC CLINICS, 1989, 7 (03) : 531 - 546
  • [25] Cutaneous Manifestations of Diabetes Mellitus: A Review
    Ana Luiza Lima
    Tanja Illing
    Sibylle Schliemann
    Peter Elsner
    American Journal of Clinical Dermatology, 2017, 18 : 541 - 553
  • [26] Cutaneous Manifestations of Diabetes Mellitus: A Review
    Lima, Ana Luiza
    Illing, Tanja
    Schliemann, Sibylle
    Elsner, Peter
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2017, 18 (04) : 541 - 553
  • [27] THE CUTANEOUS MANIFESTATIONS OF DIABETES-MELLITUS
    HUNTLEY, AC
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1982, 7 (04) : 427 - 455
  • [28] CUTANEOUS MANIFESTATIONS IN DIABETES-MELLITUS
    SKRIPKIN, YK
    SAMSONOV, VA
    ABRAMOVA, EA
    VESTNIK AKADEMII MEDITSINSKIKH NAUK SSSR, 1989, (05): : 54 - 57
  • [29] CUTANEOUS MANIFESTATIONS OF DIABETES-MELLITUS
    JELINEK, JE
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1994, 33 (09) : 605 - 617
  • [30] CUTANEOUS MANIFESTATIONS OF DIABETES-MELLITUS
    PEREZ, MI
    KOHN, SR
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (04) : 519 - 531